Literature DB >> 33226834

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations.

Olivia C Leavy1, Shwu-Fan Ma2, Philip L Molyneaux3,4, Toby M Maher3,4,5, Justin M Oldham6, Carlos Flores7,8,9,10, Imre Noth2, R Gisli Jenkins11,12, Frank Dudbridge1, Louise V Wain1,13, Richard J Allen1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33226834      PMCID: PMC7958523          DOI: 10.1164/rccm.202008-3211LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  16 in total

1.  A better coefficient of determination for genetic profile analysis.

Authors:  Sang Hong Lee; Michael E Goddard; Naomi R Wray; Peter M Visscher
Journal:  Genet Epidemiol       Date:  2012-04       Impact factor: 2.135

Review 2.  Translational genomics and precision medicine: Moving from the lab to the clinic.

Authors:  Eleftheria Zeggini; Anna L Gloyn; Anne C Barton; Louise V Wain
Journal:  Science       Date:  2019-09-27       Impact factor: 47.728

3.  Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

Authors:  Ganesh Raghu; Shih-Yin Chen; Wei-Shi Yeh; Brad Maroni; Qian Li; Yuan-Chi Lee; Harold R Collard
Journal:  Lancet Respir Med       Date:  2014-05-27       Impact factor: 30.700

Review 4.  The contribution of genetic variants to disease depends on the ruler.

Authors:  John S Witte; Peter M Visscher; Naomi R Wray
Journal:  Nat Rev Genet       Date:  2014-09-16       Impact factor: 53.242

5.  UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

Authors:  Cathie Sudlow; John Gallacher; Naomi Allen; Valerie Beral; Paul Burton; John Danesh; Paul Downey; Paul Elliott; Jane Green; Martin Landray; Bette Liu; Paul Matthews; Giok Ong; Jill Pell; Alan Silman; Alan Young; Tim Sprosen; Tim Peakman; Rory Collins
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

6.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

7.  Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Authors:  Richard J Allen; Joanne Porte; Rebecca Braybrooke; Carlos Flores; Tasha E Fingerlin; Justin M Oldham; Beatriz Guillen-Guio; Shwu-Fan Ma; Tsukasa Okamoto; Alison E John; Ma'en Obeidat; Ivana V Yang; Amanda Henry; Richard B Hubbard; Vidya Navaratnam; Gauri Saini; Norma Thompson; Helen L Booth; Simon P Hart; Mike R Hill; Nik Hirani; Toby M Maher; Robin J McAnulty; Ann B Millar; Philip L Molyneaux; Helen Parfrey; Doris M Rassl; Moira K B Whyte; William A Fahy; Richard P Marshall; Eunice Oballa; Yohan Bossé; David C Nickle; Don D Sin; Wim Timens; Nick Shrine; Ian Sayers; Ian P Hall; Imre Noth; David A Schwartz; Martin D Tobin; Louise V Wain; R Gisli Jenkins
Journal:  Lancet Respir Med       Date:  2017-10-20       Impact factor: 102.642

8.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

9.  Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis.

Authors:  Delphine Guillotin; Adam R Taylor; Manuela Platé; Andy D Blanchard; Rachel C Chambers; Paul F Mercer; Lindsay M Edwards; Ross Haggart; Gino Miele; Robin J McAnulty; Toby M Maher; Robert E Hynds; Mariam Jamal-Hanjani; Richard P Marshall; Andrew J Fisher
Journal:  Thorax       Date:  2020-11-19       Impact factor: 9.139

10.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Authors:  Tasha E Fingerlin; Elissa Murphy; Weiming Zhang; Anna L Peljto; Kevin K Brown; Mark P Steele; James E Loyd; Gregory P Cosgrove; David Lynch; Steve Groshong; Harold R Collard; Paul J Wolters; Williamson Z Bradford; Karl Kossen; Scott D Seiwert; Roland M du Bois; Christine Kim Garcia; Megan S Devine; Gunnar Gudmundsson; Helgi J Isaksson; Naftali Kaminski; Yingze Zhang; Kevin F Gibson; Lisa H Lancaster; Joy D Cogan; Wendi R Mason; Toby M Maher; Philip L Molyneaux; Athol U Wells; Miriam F Moffatt; Moises Selman; Annie Pardo; Dong Soon Kim; James D Crapo; Barry J Make; Elizabeth A Regan; Dinesha S Walek; Jerry J Daniel; Yoichiro Kamatani; Diana Zelenika; Keith Smith; David McKean; Brent S Pedersen; Janet Talbert; Raven N Kidd; Cheryl R Markin; Kenneth B Beckman; Mark Lathrop; Marvin I Schwarz; David A Schwartz
Journal:  Nat Genet       Date:  2013-04-14       Impact factor: 38.330

View more
  2 in total

Review 1.  COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.

Authors:  Alison E John; Chitra Joseph; Gisli Jenkins; Amanda L Tatler
Journal:  Immunol Rev       Date:  2021-05-24       Impact factor: 10.983

2.  The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.

Authors:  Xiaozheng Wu; Wen Li; Zhenliang Luo; Yunzhi Chen
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.